SweetValueLab
Write for us

AbbVie Inc. — Financial Statements & Ratios

ABBV
NYSEHealthcareDrug Manufacturers - GeneralCIK 0001551152abbvie.comAbout ABBV
Last close · Oct 16, 2026285.42+2.02 (+0.71%)
Market cap$504.4B

Key indicators

Revenue64.4BTTM+10.4% on a year earlier+9.3% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
32.8B 33.3B+1.6%45.8B+37.7%56.2B+22.7%58.1B+3.3%54.3B−6.4%56.3B+3.7%61.2B+8.6%64.4B+10.4%67.6B 73.5B 79.0B
— 1.6% 37.7% 22.7% 3.3% -6.4% 3.7% 8.6% 10.4% 10.6% 8.7% 7.5%
$3.66 $5.28+44.3%$2.72−48.5%$6.45+137.1%$6.63+2.8%$2.72−59.0%$2.39−12.1%$2.36−1.3%$3.54+67.8%$13.92 $16.38 $17.88
Profitability
19.5% 39.0%+19.5 pt24.8%−14.2 pt31.9%+7.1 pt31.2%−0.7 pt23.5%−7.7 pt16.2%−7.3 pt24.6%+8.4 pt26.2%+7.4 pt· · ·
17.4% 23.7%+6.3 pt10.1%−13.6 pt20.5%+10.5 pt20.4%−0.2 pt9.0%−11.4 pt7.6%−1.4 pt6.9%−0.7 pt9.8%+3.3 pt· · ·
-67.3% -96.5%−29.1 pt35.3%+131.8 pt74.9%+39.6 pt68.6%−6.3 pt46.9%−21.7 pt128.7%+81.7 pt-129.2%−257.9 pt— · · ·
Cash
12.8B 12.8B−0.1%16.8B+31.5%22.0B+31.0%24.2B+10.3%22.1B−9.0%17.8B−19.2%17.8B−0.1%18.2B−0.2%· · ·
39.0% 38.4%−0.7 pt36.7%−1.7 pt39.1%+2.5 pt41.8%+2.6 pt40.6%−1.2 pt31.7%−9.0 pt29.1%−2.5 pt28.3%−3.0 pt· · ·
5.6B 6.4B+14.1%7.7B+21.2%9.3B+20.0%10.0B+8.4%10.5B+4.9%11.0B+4.6%11.7B+5.7%— · · ·
Balance sheet
-4.77x -8.17x−3.39x6.58x+14.75x4.98x−1.60x3.67x−1.31x5.73x+2.07x20.19x+14.46x-20.64x−40.83x-11.93x+373.21x· · ·
1.55B 1.48B−4.0%1.67B+12.7%1.78B+6.2%1.78B+0.1%1.77B−0.3%1.77B+0.0%1.77B+0.0%1.77B+0.0%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.